Home LiteratureArticle Details
PMID: 8174954 Published · ppublish English Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.

Gut ·Vol. 34 ·No. 8 ·1993-08-00 ·Pages 1060-5

el-Omar E, Penman I, Dorrian CA, Ardill JE, McColl KE

Abstract

Helicobacter pylori (H pylori) raises serum gastrin but it is unclear whether this stimulates increased acid secretion. Gastrin mediated acid secretion and plasma gastrin after the intravenous infusion of gastrin releasing peptide was studied in nine H pylori negative and nine H pylori positive healthy volunteers, and in 11 duodenal ulcer patients. Nine of the last group were re-examined one month after eradication of H pylori. The median acid output (mmol/h) to gastrin releasing peptide (40 pmol/kg/h) in the H pylori positive healthy volunteers was 15.1 (range 3.3-38.3), which was three times that of the H pylori negative healthy volunteers (median = 5.5, range 1.0-9.0) (p < 0.02). The median acid output in the duodenal ulcer patients with H pylori was 37 (range 8.5-57), which was > six times that of the H pylori negative healthy volunteers. Eradication of H pylori in the duodenal ulcer patients lowered their acid secretion by a median of 66% (range 30%-80%) (p < 0.01) and to values equivalent to the H pylori positive healthy volunteers. The pepsin output in response to gastrin releasing peptide followed the same pattern as the acid output. The median plasma gastrin concentrations during gastrin releasing peptide were similar in the H pylori positive duodenal ulcer patients (150 ng/l, range 95-400) and H pylori positive healthy volunteers (129 ng/l, range 23-420) and both were appreciably higher than H pylori negative healthy volunteers (60 ng/l, range 28-135) (p < 0.005 for each). Eradication of H pylori lowered the plasma gastrin in the duodenal ulcer patients to values equivalent to the H pylori negative healthy volunteers. These findings show a threefold increase in acid secretion in H pylori positive healthy volunteers that is explained by H pylori induced hypergastrinaemia and a sixfold increase in acid secretion in the duodenal ulcer patients that is explained by the combination of H pylori induced hypergastrinaemia and an exaggerated acid response to stimulation by gastrin. Eradicating H pylori lowers gastrin mediated acid secretion by 66% in duodenal ulcer patients as a result of the resolution of the hypergastrinaemia. Increased gastrin mediated acid secretion seems to be the key factor in the pathophysiology of duodenal ulceration and explains the role of H pylori infection in the disorder.

MeSH Terms
Amoxicillin/pharmacology,therapeutic use Anti-Bacterial Agents/administration & dosage Basal Metabolism Breath Tests Carbon Radioisotopes Duodenal Ulcer/drug therapy,metabolism,microbiology Female Gastric Acid/metabolism Gastrin-Releasing Peptide Gastrins/blood,drug effects Helicobacter Infections/complications,drug therapy,metabolism Helicobacter pylori/drug effects Humans Infusions, Intravenous Male Metronidazole/pharmacology,therapeutic use Organometallic Compounds/pharmacology,therapeutic use Pepsin A/drug effects,metabolism Peptides/administration & dosage Time Factors Urea/metabolism
Chemicals
Anti-Bacterial Agents Carbon Radioisotopes Gastrins Organometallic Compounds Peptides Metronidazole Gastrin-Releasing Peptide Amoxicillin Urea Pepsin A bismuth tripotassium dicitrate
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
el-Omar E
University Department of Medicine and Therapeutics, Western Infirmary, Glasgow.
Penman I
Dorrian C A
Ardill J E
McColl K E
References (29)
29 references, click to expand
  1. Gastrin is a major mediator of the gastric phase of acid secretion in dogs: proof by monoclonal antibody neutralization.
    Gastroenterology. 1989 Dec;97(6):1406-13 PMID: 2583408
  2. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
    Lancet. 1988 Dec 24-31;2(8626-8627):1437-42 PMID: 2904568
  3. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.
    Am J Gastroenterol. 1990 Apr;85(4):394-8 PMID: 2327380
  4. Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
    Lancet. 1990 May 26;335(8700):1233-5 PMID: 1971318
  5. Role of gastrin in bombesin-stimulated somatostatin release.
    Gastroenterology. 1990 Nov;99(5):1297-302 PMID: 1976561
  6. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects.
    Scand J Gastroenterol. 1991 Mar;26(3):339-46 PMID: 1853158
  7. Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects.
    Aliment Pharmacol Ther. 1991 Jun;5(3):283-90 PMID: 1888827
  8. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach.
    Dig Dis Sci. 1992 Mar;37(3):409-16 PMID: 1346517
  9. Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients.
    Gut. 1992 May;33(5):601-3 PMID: 1612474
  10. Influence of smoking on basal and on vagally and maximally stimulated gastric acid and pepsin secretion.
    Scand J Gastroenterol. 1992;27(3):208-12 PMID: 1502483
  11. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease.
    Lancet. 1992 Oct 17;340(8825):930-2 PMID: 1357347
  12. Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects.
    Scand J Gastroenterol. 1992 Oct;27(10):857-62 PMID: 1439539
  13. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17.
    Gut. 1993 Jun;34(6):757-61 PMID: 8314507
  14. Stomach size and its relation to chronic peptic ulcer.
    AMA Arch Pathol. 1952 Nov;54(5):407-22 PMID: 12996173
  15. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism.
    BMJ. 1989 Dec 16;299(6714):1504-5 PMID: 2514864
  16. Gastric secretion tests.
    Gastroenterology. 1967 Mar;52(3):587-9 PMID: 6019974
  17. Use of pentagastrin in a test of gastric acid secretion.
    Lancet. 1967 Sep 16;2(7516):585-8 PMID: 4166828
  18. Theorigin and survival of gastric parietal cells in the mouse.
    Anat Rec. 1968 Sep;162(1):99-110 PMID: 5697627
  19. Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats.
    Gastroenterology. 1969 Aug;57(2):147-55 PMID: 5799673
  20. Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer.
    J Clin Invest. 1975 Feb;55(2):330-7 PMID: 1127103
  21. Radioautographic and quantitative studies on parietal and peptic cell kinetics in the mouse. A selective effect of gastrin on parietal cell proliferation.
    Gastroenterology. 1975 Aug;69(2):416-26 PMID: 1150048
  22. Pentagastrin dose-response in peptic ulcer disease.
    Scand J Gastroenterol. 1975;10(7):705-14 PMID: 1103272
  23. Radioimmunoassay of GI hormones.
    Clin Endocrinol Metab. 1979 Jul;8(2):265-80 PMID: 383319
  24. Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients.
    J Clin Invest. 1980 Feb;65(2):555-62 PMID: 7356694
  25. Pepsin 1 secretion in chronic peptic ulceration.
    Gut. 1980 Sep;21(9):766-71 PMID: 6776016
  26. Bombesin: action on gut hormones and calcium in man.
    J Clin Endocrinol Metab. 1982 May;54(5):980-5 PMID: 7061703
  27. Kinetic assay of human pepsin with albumin-bromphenol blue as substrate.
    Clin Chem. 1983 Mar;29(3):447-51 PMID: 6402323
  28. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy.
    Gastroenterology. 1986 Mar;90(3):540-4 PMID: 3943686
  29. Serological diagnosis of primary Sjögren's syndrome by means of human recombinant La (SS-B) as nuclear antigen.
    Lancet. 1987 Jul 4;2(8549):1-3 PMID: 2885503
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
1993-08-00
Pages
1060-5
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1374354
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]